Human LILRB2 / ILT4 / LIR-2 Protein (His Tag)
CD85D,ILT-4,ILT4,LIR-2,LIR2,MIR-10,MIR10
- 100ug (NPP2309) Please inquiry
Catalog Number | P14132-H08H |
---|---|
Organism Species | Human |
Host | Human Cells |
Synonyms | CD85D,ILT-4,ILT4,LIR-2,LIR2,MIR-10,MIR10 |
Molecular Weight | The recombinant human LILRB2 consists of 451 amino acids and predicts a molecular mass of 49.2 KDa. It migrates as an approximately 66 KDa band in SDS-PAGE under reducing conditions. |
predicted N | Gln 22 |
SDS-PAGE | |
Purity | > 90 % as determined by SDS-PAGE |
Protein Construction | A DNA sequence encoding the human LILRB2 (AAH36827.1) (Met1-Val461) was expressed with a polyhistidine tag at the C-terminus. |
Bio-activity | |
Research Area | Immunology |Adaptive Immunity |Major Histocompatibility Complex (MHC) |MHC Class I |
Formulation | Lyophilized from sterile PBS, pH 7.4 1. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA. |
Background | ILT4, also known as LILRB2, is a member of the the subfamily B class of LIR receptors which contain two or four extracellular immunoglobulin domains, a transmembrane domain, and two to four cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs). ILT4 gene is a member of the leukocyte immunoglobulin-like receptor (LIR) family. Multiple transcript variants encoding different isoforms have been found for ILT4 gene. ILT4 is expressed on immune cells where it binds to MHC class I molecules on antigen-presenting cells and transduces a negative signal that inhibits stimulation of an immune response. It is thought to control inflammatory responses and cytotoxicity to help focus the immune response and limit autoreactivity. |
Reference |